# Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on Tamoxifen

> **NCT03504631** · — · UNKNOWN · sponsor: **Trisakti University** · enrollment: 117 (estimated)

## Conditions studied

- Breast Cancer Female

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT03504631
- **Lead sponsor:** Trisakti University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-01
- **Primary completion:** 2018-10-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 117 (ESTIMATED)
- **Last updated:** 2018-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03504631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03504631, "Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on Tamoxifen". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03504631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*